Funds · CGEM

Who owns CGEM?

Institutional ownership of Cullinan Therapeutics Inc. from Form 13F, Q2 2026

184 institutional managers reported holding Cullinan Therapeutics Inc. (CGEM) in Form 13F filings for Q2 2026, with 71,706,606 shares worth $1.3B. The largest reported holder was MPM Bioimpact LLC. Managers that filed both quarters added a net 6,130,851 shares (+9.4%). 29 opened new positions and 20 sold out.

Funds holding
184
Value held
$1.3B
New / sold out
29 / 20
Net shares, same filers
+9.4%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of CGEM

FundValueShare of 13F holdingsSharesMove
MPM Bioimpact LLC$177M13.6%9,731,341Added
Lynx1 Capital Management LP$163M12.5%8,963,500Unchanged
BVF Inc$105M8.0%5,750,683Unchanged
BlackRock, Inc.$95.3M7.3%5,232,766Added
Price T Rowe Associates Inc$69.7M5.3%3,825,950Added
State Street Corp$66.8M5.1%3,668,627Added
Kynam Capital Management, LP$56.7M4.3%3,114,132Unchanged
Vanguard Capital Management LLC$47.6M3.6%2,614,066Added
RTW Investments, LP$43.1M3.3%2,364,347Added
Siren, L.L.C.$34.5M2.6%1,893,410Added
Geode Capital Management, LLC$28.2M2.2%1,547,309Added
Blue Owl Capital Holdings LP$28.0M2.1%1,539,764Trimmed
Venrock Adviser, LLC$25.1M1.9%1,379,965Unchanged
Boothbay Fund Management, LLC$19.7M1.5%1,082,611Trimmed
Dimensional Fund Advisors LP$19.1M1.5%1,046,694Added
Goldman Sachs Group Inc$18.2M1.4%1,001,598Added
Affinity Asset Advisors, LLC$15.9M1.2%875,760Added
Vanguard Portfolio Management LLC$13.5M1.0%738,741Added
Boone Capital Management LLC$12.8M1.0%704,442New
Elmind Capital, LP$12.6M1.0%690,000Added
Morgan Stanley$11.5M0.9%629,035Added
Twin Focus Capital Partners, LLC$10.8M0.8%595,489Unchanged
AQR Capital Management LLC$10.6M0.8%581,338Added
Northern Trust Corp$10.4M0.8%571,080Added
Bank of America Corp$9.3M0.7%510,325Trimmed

Share of 13F holdings is each fund's shares as a share of the 71,706,606 CGEM shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. MPM Bioimpact LLC Added+$37.9M
  2. Price T Rowe Associates Inc Added+$32.7M
  3. State Street Corp Added+$20.5M
  4. BlackRock, Inc. Added+$14.3M
  5. Boone Capital Management LLC New+$12.8M
  6. Siren, L.L.C. Added+$12.7M
  7. RTW Investments, LP Added+$12.0M
  8. Goldman Sachs Group Inc Added+$9.9M
  9. Perceptive Advisors LLC New+$7.8M
  10. Adage Capital Partners GP, L.l.c. New+$4.3M

Biggest sellers in Q2 2026

  1. Marshall Wace, LLP Trimmed-$17.9M
  2. Nextech Invest Ltd. Sold out-$16.2M
  3. Point72 Asset Management, L.P. Trimmed-$15.1M
  4. Blue Owl Capital Holdings LP Trimmed-$6.7M
  5. Soleus Capital Management, L.P. Trimmed-$6.6M
  6. Nuveen, LLC Trimmed-$6.1M
  7. Deerfield Management Company, L.p. Sold out-$5.5M
  8. Two Sigma Investments, LP Trimmed-$4.5M
  9. Orbimed Advisors LLC Sold out-$3.5M
  10. Schroder Investment Management Group Sold out-$2.3M

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $223M and sold $102M; 84 added and 46 trimmed.

Schedule 13D and 13G filings on CGEM

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about CGEM ownership

Who owns CGEM stock?
184 institutional investment managers reported CGEM positions in their Form 13F filings for Q2 2026, holding 71,706,606 shares worth $1.3B in total. MPM Bioimpact LLC reported the largest position.
Are funds buying or selling CGEM?
In Q2 2026, 29 managers opened new CGEM positions, 84 added, 46 trimmed and 20 sold out. Managers that filed in both quarters added a net 6,130,851 shares.
How current is this CGEM institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CGEM by CUSIP. Options are left out. CGEM news and filings · CGEM insider trades · Top funds